Insider Selling: Mirion Technologies, Inc. (NYSE:MIR) CEO Sells 7,500 Shares of Stock

Mirion Technologies, Inc. (NYSE:MIR) CEO Thomas D. Logan sold 7,500 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $14.11, for a total transaction of $105,825.00. Following the sale, the chief executive officer now owns 1,544,017 shares of the company’s stock, valued at approximately $21,786,079.87. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Thomas D. Logan also recently made the following trade(s):

• On Tuesday, September 24th, Thomas D. Logan sold 7,500 shares of Mirion Technologies stock. The shares were sold at an average price of $10.47, for a total transaction of $78,525.00.
• On Friday, August 23rd, Thomas D. Logan sold 7,500 shares of Mirion Technologies stock. The stock was sold at an average price of $11.00, for a total transaction of $82,500.00.

Mirion Technologies Stock Performance

MIR traded down $0.15 during trading on Monday, hitting $14.21. The stock had a trading volume of 2,754,554 shares, compared to its average volume of 1,245,035. The firm has a market capitalization of $3.23 billion, a P/E ratio of -34.49 and a beta of 0.79. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.55 and a current ratio of 2.18. Mirion Technologies, Inc. has a twelve month low of $6.70 and a twelve month high of $14.80. The company’s 50-day moving average price is $11.45 and its 200 day moving average price is $10.89.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.03. The business had revenue of $207.10 million for the quarter, compared to analyst estimates of $210.77 million. Mirion Technologies had a negative net margin of 7.80% and a positive return on equity of 3.81%. The business’s revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.08 earnings per share. On average, equities research analysts forecast that Mirion Technologies, Inc. will post 0.31 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, B. Riley assumed coverage on Mirion Technologies in a research note on Thursday, September 26th. They set a “buy” rating and a $14.00 price objective for the company.

Institutional Trading of Mirion Technologies

Several hedge funds have recently modified their holdings of the business. Vanguard Group Inc. raised its position in Mirion Technologies by 0.8% in the first quarter. Vanguard Group Inc. now owns 21,308,031 shares of the company’s stock worth $242,272,000 after acquiring an additional 159,404 shares in the last quarter. Swedbank AB acquired a new position in shares of Mirion Technologies during the 1st quarter worth $122,546,000. Dimensional Fund Advisors LP increased its holdings in shares of Mirion Technologies by 20.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 6,111,933 shares of the company’s stock valued at $65,642,000 after purchasing an additional 1,031,966 shares in the last quarter. American Century Companies Inc. lifted its stake in shares of Mirion Technologies by 61.9% in the second quarter. American Century Companies Inc. now owns 3,942,571 shares of the company’s stock valued at $42,343,000 after purchasing an additional 1,507,101 shares during the period. Finally, Schwartz Investment Counsel Inc. boosted its holdings in Mirion Technologies by 1.3% during the second quarter. Schwartz Investment Counsel Inc. now owns 1,519,300 shares of the company’s stock worth $16,317,000 after buying an additional 20,000 shares in the last quarter. 78.51% of the stock is owned by institutional investors and hedge funds.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.